NHMRC to develop new treatment guidelines for transgender youth
It follows the decision by the Queensland Government to restrict the prescription of puberty blockers and cross-sex hormones in its paediatric transgender clinics.
The NHMRC is to develop new national guidelines for transgender youth amid the ongoing debate about the prescription of puberty blockers and cross-sex hormones.
Announced this afternoon by Federal Health Minister Mark Butler, he said the aim was to give the community confidence that patients are receiving appropriate care.
“This process will be driven by evidence and conducted by our most eminent medical researchers and clinicians,” Mr Butler said.
It follows the Queensland Government’s decision this week to ban the initiation of cross-sex hormones and puberty blockers in its public hospitals to children and adolescents diagnosed with gender dysphoria.
